Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cis-platinum complex with retained prolactin receptor specific binding.

B Hecquet, J P Peyrat, J Bonneterre

    Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion.

    The International journal of biological markers·2017
    Same author

    Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.

    Methods in enzymology·2016
    Same author

    [Systemic treatment of brain metastases from breast cancer].

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2015
    Same author

    A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    [What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].

    Gynecologie, obstetrique & fertilite·2014
    Same journal

    Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Euphol targets key oncogenic processes and promotes chemoprevention in organoid and In Vivo models of colorectal cancers.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    CAR-T cell therapy and oncolytic viruses: A synergic approach for advanced GI cancers.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    See all related articles

    Researchers synthesized two prolactin-platinum complexes. Only the cis-platinum prolactin complex binds to cell receptors, suggesting prolactin can enhance cis-platinum

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Oncology

    Background:

    • Prolactin is a pituitary hormone with diverse biological functions.
    • Platinum-based chemotherapy, like cis-platinum, is widely used but lacks specificity.
    • Targeted drug delivery aims to improve efficacy and reduce side effects of chemotherapy.

    Purpose of the Study:

    • To synthesize and characterize novel prolactin-platinum complexes.
    • To evaluate the biological activity and receptor-binding capacity of these complexes.
    • To explore the potential of prolactin as a targeting moiety for cis-platinum delivery.

    Main Methods:

    • Synthesis of two distinct prolactin-platinum complexes.
    • Radioreceptor assay to determine binding affinity to prolactin receptors.

    Related Experiment Videos

  • Comparison of binding capacity with native prolactin and cis-platinum.

    • Main Results:

    • Two complexes were successfully synthesized.
    • Only the cis-platinum prolactin complex demonstrated significant binding to cell membrane prolactin receptors.
    • This binding capacity was comparable to native prolactin.

    Conclusions:

    • The cis-platinum prolactin complex retains the receptor-binding ability of prolactin.
    • Prolactin can potentially be utilized to enhance the tumor-specific delivery of cis-platinum.
    • This approach may lead to more targeted and effective platinum-based cancer therapies.